Antigen-Specific Tolerance by Autologous Myelin Peptide–Coupled Cells: A Phase 1 Trial in Multiple Sclerosis

Tolerability Regimen Cell therapy
DOI: 10.1126/scitranslmed.3006168 Publication Date: 2013-06-05T18:34:42Z